# UBP1

## Overview
UBP1, or upstream binding protein 1, is a gene that encodes a transcription factor involved in the regulation of gene expression in human cells. The protein product of UBP1 is a member of the TFCP2/Grainyhead family of transcription factors, which also includes TFCP2 and TFCP2L1, and is characterized by a DNA-binding domain and a C-terminal sterile alpha motif domain that facilitates protein dimerization (Kotarba2018TFCP2TFCP2L1UBP1). UBP1 is ubiquitously expressed and plays a significant role in various biological processes, such as hematopoiesis, cell cycle control, and the regulation of immune-related and cytochrome P450 genes (Kotarba2018TFCP2TFCP2L1UBP1). It primarily functions in the nucleus, where it binds to specific DNA sequences upstream of target genes, thereby modulating their transcription and influencing cellular processes like differentiation and proliferation (Kotarba2018TFCP2TFCP2L1UBP1). The gene has also been implicated in clinical contexts, such as blood pressure regulation and malaria drug resistance, highlighting its potential as a target for therapeutic interventions (Koutnikova2009Identification; Simwela2020Experimentally).

## Function
UBP1, also known as upstream binding protein 1, is a transcription factor involved in regulating gene expression in human cells. It is part of the TFCP2/Grainyhead family of transcription factors, which includes TFCP2 and TFCP2L1, and shares significant sequence identity with these proteins (Kotarba2018TFCP2TFCP2L1UBP1). UBP1 is characterized by a DNA-binding domain and a C-terminal sterile alpha motif domain, which is involved in protein dimerization (Kotarba2018TFCP2TFCP2L1UBP1).

UBP1 is ubiquitously expressed in human cells and plays a role in several biological processes, including hematopoiesis, cell cycle control, and the regulation of immune-related and cytochrome P450 genes (Kotarba2018TFCP2TFCP2L1UBP1). It is primarily active in the nucleus, where it binds to specific DNA sequences upstream of target genes, influencing their transcription. This activity is crucial for modulating the transcriptional activity of various genes, impacting cellular processes such as differentiation and proliferation (Kotarba2018TFCP2TFCP2L1UBP1).

While UBP1 is involved in normal cellular functions, specific roles in healthy human cells are not detailed in the available context, indicating a need for further research to fully elucidate its functions in non-disease states (Kotarba2018TFCP2TFCP2L1UBP1).

## Clinical Significance
Mutations and alterations in the expression of the UBP1 gene have been implicated in various health conditions, particularly in the regulation of blood pressure and hypertension. The UBP1 locus has been identified as a critical determinant of blood pressure, with significant associations found between specific single nucleotide polymorphisms (SNPs) in UBP1 and blood pressure levels. These genetic variations are linked to the regulation of CYP11A, a gene involved in steroidogenesis, which may influence aldosterone secretion and contribute to hypertension (Koutnikova2009Identification). The study suggests that modulation of UBP1 activity could be a novel therapeutic approach for hypertension and cardiovascular diseases, although the association of these SNPs with blood pressure may be age-dependent, being more significant in middle-aged and younger individuals (Koutnikova2009Identification).

In addition to its role in blood pressure regulation, UBP1 has been studied in the context of malaria drug resistance. Mutations in the UBP1 gene in Plasmodium species have been associated with altered susceptibility to antimalarial drugs, indicating a potential role in the evolution of drug resistance (Xu2024Deaggregation; Simwela2020Experimentally). However, these findings are specific to malaria research and do not directly relate to human health conditions.


## References


[1. (Koutnikova2009Identification) Hana Koutnikova, Markku Laakso, Lu Lu, Roy Combe, Jussi Paananen, Teemu Kuulasmaa, Johanna Kuusisto, Hans-Ulrich Häring, Torben Hansen, Oluf Pedersen, Ulf Smith, Markolf Hanefeld, Robert W. Williams, and Johan Auwerx. Identification of the ubp1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genetics, 5(8):e1000591, August 2009. URL: http://dx.doi.org/10.1371/journal.pgen.1000591, doi:10.1371/journal.pgen.1000591. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000591)

[2. (Xu2024Deaggregation) Ruixue Xu, Lirong Lin, Zhiwei Jiao, Rui Liang, Yazhen Guo, Yixin Zhang, Xiaoxu Shang, Yuezhou Wang, Xu Wang, Luming Yao, Shengfa Liu, Xianming Deng, Jing Yuan, Xin-zhuan Su, and Jian Li. Deaggregation of mutant plasmodium yoelii de-ubiquitinase ubp1 alters mdr1 localization to confer multidrug resistance. Nature Communications, February 2024. URL: http://dx.doi.org/10.1038/s41467-024-46006-3, doi:10.1038/s41467-024-46006-3. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-46006-3)

[3. (Simwela2020Experimentally) Nelson V. Simwela, Katie R. Hughes, A. Brett Roberts, Michael T. Rennie, Michael P. Barrett, and Andrew P. Waters. Experimentally engineered mutations in a ubiquitin hydrolase, ubp-1, modulate in vivo susceptibility to artemisinin and chloroquine in plasmodium berghei. Antimicrobial Agents and Chemotherapy, June 2020. URL: http://dx.doi.org/10.1128/aac.02484-19, doi:10.1128/aac.02484-19. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1128/aac.02484-19)

[4. (Kotarba2018TFCP2TFCP2L1UBP1) Grzegorz Kotarba, Ewa Krzywinska, Anna I. Grabowska, Agnieszka Taracha, and Tomasz Wilanowski. Tfcp2/tfcp2l1/ubp1 transcription factors in cancer. Cancer Letters, 420:72–79, April 2018. URL: http://dx.doi.org/10.1016/j.canlet.2018.01.078, doi:10.1016/j.canlet.2018.01.078. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2018.01.078)